Ildong Pharmaceutical Co., Ltd. (KRX:249420)
41,700
-300 (-0.71%)
At close: Jan 9, 2026
Ildong Pharmaceutical Market Cap
Ildong Pharmaceutical has a market cap or net worth of 1.31 trillion as of January 9, 2026. Its market cap has increased by 324.15% in one year.
Market Cap
1.31T
Enterprise Value
1.41T
Revenue
575.66B
Ranking
n/a
PE Ratio
42.51
Stock Price
41,700.00
Market Cap Chart
Since August 31, 2016, Ildong Pharmaceutical's market cap has increased from 453.27B to 1.31T, an increase of 189.87%. That is a compound annual growth rate of 12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.31T | 8.31% |
| Dec 30, 2025 | 1.21T | 268.98% |
| Dec 30, 2024 | 328.76B | -34.57% |
| Dec 28, 2023 | 502.48B | -34.29% |
| Dec 29, 2022 | 764.72B | -4.31% |
| Dec 30, 2021 | 799.19B | 77.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.19T |
| LigaChem Biosciences | 6.51T |